APA (7th ed.) Citation

C, E., MB, S., B, G., H, B., MJ, B., & TS, B. (2026). Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm. Drug design, development and therapy, 20, 559325. https://doi.org/10.2147/DDDT.S559325

Chicago Style (17th ed.) Citation

C, Eslinger, Sonbol MB, George B, Babiker H, Borad MJ, and Bekaii-Saab TS. "Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm." Drug Design, Development and Therapy 20 (2026): 559325. https://doi.org/10.2147/DDDT.S559325.

MLA (9th ed.) Citation

C, Eslinger, et al. "Key Considerations for Targeting KRAS in Pancreatic Cancer: Potential Impact on the Treatment Paradigm." Drug Design, Development and Therapy, vol. 20, 2026, p. 559325, https://doi.org/10.2147/DDDT.S559325.